For Founders
Pitch your startup
We invest in HealthTech and MedTech founders who understand their problem better than anyone else. You are not pitching generalist angels. You are pitching investors who understand healthcare.
Our first pitch day drew 52 applications from founders across the UK.
Investment criteria
- Pre-seed to seed stage (typically up to £5M round)
- HealthTech, MedTech, or scientific platform
- Clear clinical problem with evidence of demand
- Team that has lived the problem, not just read about it
- Realistic regulatory pathway (MHRA, CE/UKCA, NHS)
- Unit economics that work, or a credible path to them
What you get
Smart capital
£50k-£500k aggregated across the syndicate, EIS and SEIS eligible on qualifying investments. Enough capital to matter, without making your cap table messy.
Sector expertise
34 years of GSK pharma leadership, two angel exits, and CPO-level product experience, not investors treating regulation as a footnote.
Partner network
Introductions to Scottish Enterprise (match funding £350k-£2M), Development Bank of Wales, NHS innovation pathways, Priority IP for IP strategy, and Founder Catalyst for SEIS/EIS legal readiness.
Honest feedback
If we pass, we tell you why. We aim to respond within two weeks and give reasons, not just a 'no'.
What a strong submission includes
We review every submission ourselves. These five things give us everything we need to move quickly and give you a meaningful response.
- A clear description of the clinical problem you are solving
- Your deck - including team, market, regulatory pathway, and traction
- Current raise: target size, what is already committed, and your closing timeline
- Your regulatory status or plan (MHRA, CE/UKCA, NHS DTAC, or equivalent)
- Any clinical evidence - even early-stage data strengthens the submission
What gets passed quickly
We are honest about fit early, so you do not waste weeks chasing the wrong investor. These are the most common reasons we pass at screening.
- B2C health apps without a clinical problem at the core
- Pre-revenue teams with no clinical or domain-credible co-founder
- Rounds above £5M (outside our stage focus)
- US-first regulatory strategy, unless there is a clear UK or EU pathway too.
- Submissions without a deck or without current raise details
How it works
Submit your pitch
Complete the form below. Include your deck, a brief on the clinical problem you are solving, and your current raise details. Takes around five minutes.
Initial screen
We review every submission against our investment criteria: stage, sector, team credibility, regulatory pathway. Most founders hear back within two weeks.
Introductory call
If there is a potential fit, we schedule a 30-minute call with the relevant Pulse Angels partners. We will have read your materials in advance.
Due diligence & syndicate briefing
We conduct clinical, commercial, and team diligence and prepare a briefing note for the syndicate. This typically runs 2-8 weeks from first meeting. Companies with complex regulatory situations or in novel clinical areas should allow more time.
Investment decision
We propose the investment to the syndicate members, who choose whether or not to invest. We confirm participation, handle legal, and close. You get capital, expertise, and a long-term partner.
Founder FAQ
Submit your pitch
Fill in the form below. We read every submission and aim to respond within two weeks. If we cannot progress, we will tell you why.
- Include your deck and a brief on the clinical problem
- State your current raise size and what you have closed so far